Institution · Micropore Technologies (United Kingdom)

Most cited papers from Micropore Technologies (United Kingdom)

Micropore Technologies (United Kingdom)

What are the most cited papers from Micropore Technologies (United Kingdom)?

The most cited paper from Micropore Technologies (United Kingdom) is "The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections" (David Felmingham, Reuben N. Grüneberg, 2000), with 368 citations. Next come "A UK Multicentre Study of the Antimicrobial Susceptibility of Bacterial Pathogens Causing Urinary Tract Infection" (325) and "Increased Antimicrobial Resistance Among Nonvaccine Serotypes of Streptococcus pneumoniae in the Pediatric Population After the Introduction of 7-Valent Pneumococcal Vaccine in the United States" (224).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 25 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections David Felmingham, Reuben N. Grüneberg · Journal of Antimicrobial Chemotherapy	Feb 2000	368
2	A UK Multicentre Study of the Antimicrobial Susceptibility of Bacterial Pathogens Causing Urinary Tract Infection D. J. Farrell, Ian Morrissey, David De Rubeis et al. · Journal of Infection	Feb 2003	325
3	Increased Antimicrobial Resistance Among Nonvaccine Serotypes of Streptococcus pneumoniae in the Pediatric Population After the Introduction of 7-Valent Pneumococcal Vaccine in the United States David J. Farrell, Keith P. Klugman, Michael E. Pichichero · The Pediatric Infectious Disease Journal	19 Jan 2007	224
4	Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin David Felmingham, Ralf René Reinert, Yoichi Hirakata et al. · Journal of Antimicrobial Chemotherapy Open access	Sep 2002	221
5	Trends in the Antimicrobial Susceptibility of Bacterial Respiratory Tract Pathogens - Findings of the Alexander Project 1992-1996 David Felmingham, J. W. Washington, The Alexander Project Group · Journal of Chemotherapy	1999	188
6	The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections Daryl J. Hoban, David Felmingham · Journal of Antimicrobial Chemotherapy Open access	Sep 2002	156
7	A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project David Felmingham, Reuben N. Grüneberg, The Alexander Project Group · Journal of Antimicrobial Chemotherapy	Jul 1996	156
8	Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Journal of Antimicrobial Chemotherapy	Sep 2002	155
9	Novel Mechanism of Resistance to Oxazolidinones, Macrolides, and Chloramphenicol in Ribosomal Protein L4 of the Pneumococcus Nicole Wolter, Anthony Marius Smith, David J. Farrell et al. · Antimicrobial Agents and Chemotherapy Open access	27 Jul 2005	155
10	Liquid−Liquid Membrane Dispersion in a Stirred Cell with and without Controlled Shear Serguei R. Kosvintsev, Gilda Gasparini, Richard G. Holdich et al. · Industrial & Engineering Chemistry Research Open access	22 Oct 2005	123
11	Emergence and Spread ofStreptococcus pneumoniaewitherm(B) andmef(A) Resistance David J. Farrell, Stephen G. Jenkins, Steven D. Brown et al. · Emerging infectious diseases Open access	Jun 2005	116
12	Membrane emulsification using membranes of regular pore spacing: Droplet size and uniformity in the presence of surface shear Emanuela Egidi, Gilda Gasparini, Richard G. Holdich et al. · Journal of Membrane Science Open access	28 Jun 2008	104
13	The need for antimicrobial resistance surveillance David Felmingham · Journal of Antimicrobial Chemotherapy	Sep 2002	103
14	Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study David J. Farrell, Stephen R. Douthwaite, Ian Morrissey et al. · Antimicrobial Agents and Chemotherapy Open access	21 May 2003	101
15	The Alexander Project: the benefits from a decade of surveillance David Felmingham, Anthony Robert White, Michael R. Jacobs et al. · Journal of Antimicrobial Chemotherapy	Oct 2005	92
16	Membrane Emulsification with Oscillating and Stationary Membranes Richard G. Holdich, Marijana M. Dragosavac, Goran T. Vladisavljević et al. · Industrial & Engineering Chemistry Research Open access	23 Mar 2010	87
17	Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm (B)- and mef (A)-Mediated Macrolide Resistance David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Journal of Clinical Microbiology Open access	Feb 2004	85
18	Surveillance of resistance in bacteria causing community‐acquired respiratory tract infections David Felmingham, Charles H. Feldman, Waleria Hryniewicz et al. · Clinical Microbiology and Infection Open access	2002	82
19	Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study Daryl J. Hoban, Ken B. Waites, David Felmingham · Diagnostic Microbiology and Infectious Disease	Apr 2003	81
20	In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against Streptococcus pneumoniae with Macrolide Resistance Due to Ribosomal Mutations David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Antimicrobial Agents and Chemotherapy Open access	23 Jul 2004	79
21	Global distribution of TEM-1 and ROB-1 β-lactamases in Haemophilus influenzae David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Journal of Antimicrobial Chemotherapy	11 Aug 2005	77
22	Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification Gilda Gasparini, Serguei R. Kosvintsev, Michael T. Stillwell et al. · Colloids and Surfaces B Biointerfaces Open access	27 Aug 2007	77
23	Controlled production of oil-in-water emulsions containing unrefined pumpkin seed oil using stirred cell membrane emulsification Marijana M. Dragosavac, Milan Sovilj, Serguei R. Kosvintsev et al. · Journal of Membrane Science Open access	24 May 2008	77
24	Stirred Cell Membrane Emulsification and Factors Influencing Dispersion Drop Size and Uniformity Michael T. Stillwell, Richard G. Holdich, Serguei R. Kosvintsev et al. · Industrial & Engineering Chemistry Research Open access	2007	76
25	Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002 Ian Morrissey, Ray Burnett, Louise Viljoen et al. · Journal of Infection	21 Apr 2004	74
26	In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates David Felmingham, M J Robbins, K Ingley et al. · Journal of Antimicrobial Chemotherapy Open access	Jun 1997	71
27	Activities of Fluoroquinolones against Streptococcus pneumoniae Type II Topoisomerases Purified as Recombinant Proteins Ian Morrissey, John T. George · Antimicrobial Agents and Chemotherapy Open access	Nov 1999	64
28	Pore design and engineering for filters and membranes Richard G. Holdich, Serguei R. Kosvintsev, Iain Cumming et al. · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences Open access	2 Dec 2005	59
29	Stirred cell membrane emulsification for multiple emulsions containing unrefined pumpkin seed oil with uniform droplet size Marijana M. Dragosavac, Richard G. Holdich, Goran T. Vladisavljević et al. · Journal of Membrane Science Open access	17 Dec 2011	59
30	Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations Ian Morrissey · Journal of Antimicrobial Chemotherapy	May 2002	57
31	Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001–2002 Suzanne J. C. Verhaegh, André Streefland, Joy K. Dewnarain et al. · Microbiology Open access	29 Mar 2008	56
32	Membrane emulsification: Droplet size and uniformity in the absence of surface shear Serguei R. Kosvintsev, Gilda Gasparini, Richard G. Holdich · Journal of Membrane Science Open access	17 Jan 2008	56
33	Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002 David J. Farrell · Journal of Antimicrobial Chemotherapy	20 Jul 2004	55
34	Instrumentation in antimicrobial susceptibility testing David Felmingham, Derek F. J. Brown · Journal of Antimicrobial Chemotherapy	Jul 2001	54
35	The Macrolide Resistance Genes erm (B) and mef (E) Are Carried by Tn 2010 in Dual-Gene Streptococcus pneumoniae Isolates Belonging to Clonal Complex CC271 María Del Grosso, John G. E. Northwood, David J. Farrell et al. · Antimicrobial Agents and Chemotherapy Open access	21 Aug 2007	54
36	Microbiological profile of telithromycin, the first ketolide antimicrobial David Felmingham · Clinical Microbiology and Infection Open access	2001	50
37	Activities of Telithromycin against 13,874 Streptococcus pneumoniae Isolates Collected between 1999 and 2003 David J. Farrell, David Felmingham · Antimicrobial Agents and Chemotherapy Open access	22 Apr 2004	49
38	The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp Geoffrey L Ridgway, Hanna Salman, M J Robbins et al. · Journal of Antimicrobial Chemotherapy	Dec 1997	46
39	Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones Ian Morrissey · Journal of Antimicrobial Chemotherapy	Apr 2000	46
40	Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types Mushtaq Ahmad Khan, M. van der Wal, D. J. Farrell et al. · Journal of Antimicrobial Chemotherapy Open access	31 Jan 2008	42
41	Production of Porous Silica Microparticles by Membrane Emulsification Marijana M. Dragosavac, Goran T. Vladisavljević, Richard G. Holdich et al. · Langmuir Open access	7 Nov 2011	42
42	Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999–2003) Gian Carlo Schito, David Felmingham · International Journal of Antimicrobial Agents	10 Nov 2005	41
43	Freeze-drying and cryopreservation of bacteria Stephen F. Perry · Molecular Biotechnology	Feb 1998	41
44	Spontaneous emulsification of water in oil at appreciable interfacial tensions Pedro Santos Silva, S.A. Zhdanov, Victor Mikhilovich Starov et al. · Colloids and Surfaces A Physicochemical and Engineering Aspects Open access	16 May 2016	40
45	Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999–2000) David Felmingham, David J. Farrell, Ralf René Reinert et al. · Journal of Infection	22 Sep 2003	38
46	High throughput membrane emulsification using a single‐pass annular flow crossflow membrane Richard G. Holdich, Marijana M. Dragosavac, Bruce Williams et al. · AIChE Journal Open access	27 Feb 2020	37
47	Telithromycin Resistance in Streptococcus pneumoniae Is Conferred by a Deletion in the Leader Sequence of erm (B) That Increases rRNA Methylation Nicole Wolter, Anthony Marius Smith, David J. Farrell et al. · Antimicrobial Agents and Chemotherapy Open access	4 Dec 2007	37
48	Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season David Felmingham, M J Robbins, Y. Tesfaslasie et al. · Journal of Antimicrobial Chemotherapy	Mar 1998	35
49	Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study Steven D. Brown, David J. Farrell, Ian Morrissey · Journal of Clinical Microbiology Open access	Nov 2004	34
50	Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999–2000 Daryl J. Hoban, Fernando Baquero, Vaughan Reed et al. · International Journal of Infectious Diseases Open access	18 Jul 2005	34

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.